Fig. 5: Neutralizing antibody responses before and after the two study vaccinations measured using two different assays. | Nature Communications

Fig. 5: Neutralizing antibody responses before and after the two study vaccinations measured using two different assays.

From: Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Fig. 5

Responses shown Geometric mean concentrations of neutralizing antibodies (with 95% CI bars) and with seroconversion rates (SCR) and geometric mean-fold rises (GMFR) from baseline indicated below. Values shown are for N participants (indicated in each column) at each timepoint.

Back to article page